+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
EGFR Tests Market - Global Forecast 2026-2032- Product Image
EGFR Tests Market - Global Forecast 2026-2032- Product Image
Sale

EGFR Tests Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6118374
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The EGFR Tests Market is projected to reach USD 1.84 Billion in 2026. It is expected to continue growing at a CAGR of 8.48%, reaching USD 3.01 Billion by 2032.

EGFR Tests: Executive Summary and Strategic Context

EGFR tests identify alterations in the epidermal growth factor receptor gene to support diagnosis, treatment selection, and disease monitoring, particularly in non-small-cell lung cancer. Their clinical value is tied to accurate variant detection, timely reporting, and alignment with targeted therapies. Adoption is shaped by laboratory capability, specimen quality, reimbursement, guideline integration, and access to molecular oncology services.

How Precision Oncology Is Reshaping EGFR Testing

The EGFR testing landscape is shifting from isolated mutation checks toward broader molecular profiling, reflex testing, and integrated diagnostic pathways. Tissue and liquid-biopsy workflows are increasingly considered complementary, while laboratories emphasize analytical sensitivity, standardized interpretation, and rapid turnaround. These changes make interoperability between pathology, molecular laboratories, oncology teams, and treatment systems increasingly important.

Artificial Intelligence Strengthens Interpretation and Workflow Efficiency

Artificial intelligence can support EGFR testing by improving image analysis, prioritizing specimens, assisting variant interpretation, identifying quality issues, and connecting molecular findings with clinical records. Its value depends on representative validation data, transparent performance monitoring, cybersecurity, and human oversight. AI should augment qualified laboratory and clinical decisions rather than replace confirmatory testing or multidisciplinary review.

Regional Insights: Access and Infrastructure Remain Uneven

North America is characterized by advanced molecular laboratories, established oncology networks, and growing use of comprehensive profiling. Europe benefits from coordinated clinical guidance and sophisticated diagnostic infrastructure, although access varies across health systems. Asia-Pacific combines strong capabilities in countries such as Japan, South Korea, Australia, China, and India with substantial differences in affordability and laboratory reach. Latin America continues to expand precision-oncology capacity while facing reimbursement and logistics constraints. The Middle East is developing specialized cancer centers and referral networks, whereas Africa remains focused on expanding pathology access, sample transport, and molecular-testing infrastructure.

Group Insights: Policy Alignment Shapes Testing Adoption

The ASEAN group reflects varied laboratory maturity and healthcare financing, making regional referral models and harmonized protocols valuable. BRICS members span substantial differences in public-sector capacity, domestic manufacturing, and access to advanced diagnostics. The European Union benefits from cross-border scientific collaboration and regulatory coordination, while the G7 generally combines strong research ecosystems with established molecular-testing pathways. GCC countries are investing in centralized, high-capability healthcare services, and NATO members may benefit from interoperable procurement, research, and health-security frameworks, although these groups are not uniform healthcare markets.

Country Insights: National Systems Determine Clinical Reach

Australia and Canada have structured health systems and specialist networks but must address geographic access. Brazil, Mexico, India, and Russia face significant regional variation in laboratory availability and affordability. China is expanding precision-medicine infrastructure across major centers, while Japan and South Korea maintain advanced diagnostic and oncology capabilities. France, Germany, Italy, Spain, and the United Kingdom have established clinical and laboratory frameworks, with differences in reimbursement, referral pathways, and implementation. The United States has broad access to sophisticated testing, alongside complexity arising from payer policies, laboratory networks, and care fragmentation.

Actions for Leaders: Build Reliable, Equitable EGFR Testing Pathways

Industry leaders should align test selection with current clinical guidelines, validate tissue and liquid-biopsy workflows for intended uses, and establish quality controls spanning collection, transport, extraction, sequencing, and reporting. Partnerships with hospitals and reference laboratories can improve access in underserved areas. Organizations should also invest in interoperable reporting, clinician education, transparent AI governance, proficiency testing, and evidence generation that demonstrates clinical utility without overstating performance. Patient navigation and clear communication of results can further reduce delays between testing and treatment decisions.

Methodology: Evidence-Based Synthesis of the EGFR Testing Landscape

This executive summary uses a qualitative synthesis framework focused on established clinical practice, diagnostic workflow requirements, healthcare infrastructure, regulatory considerations, and regional access conditions. Insights are organized across regions, multinational groupings, and specified countries to identify recurring implementation patterns. No market estimates, market shares, forecasts, or company-specific claims are included; conclusions should be interpreted alongside current guidelines, peer-reviewed evidence, and local regulatory and reimbursement requirements.

Conclusion: Accuracy, Timeliness, and Access Define EGFR Testing Value

EGFR testing is most effective when embedded in a coordinated precision-oncology pathway that delivers accurate results quickly and links them to appropriate clinical action. The next phase of progress will depend on harmonized standards, broader molecular access, stronger specimen logistics, responsible AI adoption, and sustained collaboration among laboratories, clinicians, payers, and policymakers. Leaders that combine technical rigor with equitable implementation will be best positioned to improve the usefulness of EGFR-informed care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. EGFR Tests Market, by Test Type
7.1. Introduction
7.2. Immunohistochemistry (IHC) Tests
7.3. In Situ Hybridization (ISH)
7.4. Next-Generation Sequencing (NGS) Panels
7.5. PCR-based Assays
8. EGFR Tests Market, by Sample Type
8.1. Introduction
8.2. Liquid Biopsy
8.3. Tissue Biopsy
9. EGFR Tests Market, by Application
9.1. Introduction
9.2. Breast Cancer
9.3. Glioblastomas
9.4. Head and Neck Cancers
9.5. Non-Small Cell Lung Cancer (NSCLC)
10. EGFR Tests Market, by End-Users
10.1. Introduction
10.2. Academic & Research Institutions
10.3. Diagnostic Laboratories
10.4. Hospitals & Cancer Centers
10.5. Pharmaceutical & Biotechnology Companies
11. EGFR Tests Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. EGFR Tests Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. EGFR Tests Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 3B BlackBio Dx Limited
15.2. Abbexa Ltd.
15.3. Abbott Laboratories
15.4. Agilent Technologies, Inc.
15.5. AstraZeneca plc
15.6. Beijing ACCB Biotech Ltd.
15.7. Bio-Rad Laboratories, Inc.
15.8. Bio-Techne Corporation
15.9. Biomatik Corporation
15.10. F. Hoffmann-La Roche AG
15.11. Foundation Medicine, Inc.
15.12. Guardant Health, Inc.
15.13. Illumina, Inc.
15.14. Luminex Corporation
15.15. MyBiosource, Inc.
15.16. Myriad Genetics, Inc.
15.17. QIAGEN N.V.
15.18. RainSure Scientific
15.19. Shanghai Korain Biotech Co., Ltd.
15.20. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global EGFR Tests Market, Years Considered for the Study
FIGURE 2. Global EGFR Tests Market, Research Design
FIGURE 3. Global EGFR Tests Market, Research Framework
FIGURE 4. Global EGFR Tests Market, Data Triangulation
FIGURE 5. Global EGFR Tests Market Size, 2017-2032 (USD Million)
FIGURE 6. Global EGFR Tests Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 7. Global EGFR Tests Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global EGFR Tests Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 9. Global EGFR Tests Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global EGFR Tests Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global EGFR Tests Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global EGFR Tests Market Size, by End-Users, 2025 vs 2032 (%)
FIGURE 13. Global EGFR Tests Market Size, by End-Users, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global EGFR Tests Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global EGFR Tests Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global EGFR Tests Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global EGFR Tests Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global EGFR Tests Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global EGFR Tests Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global EGFR Tests Market Segmentation & Coverage
TABLE 2. Global EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 3. Global EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 4. Global Immunohistochemistry (IHC) Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Immunohistochemistry (IHC) Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Immunohistochemistry (IHC) Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global In Situ Hybridization (ISH) Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global In Situ Hybridization (ISH) Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global In Situ Hybridization (ISH) Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Next-Generation Sequencing (NGS) Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Next-Generation Sequencing (NGS) Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Next-Generation Sequencing (NGS) Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global PCR-based Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global PCR-based Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global PCR-based Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 17. Global Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Liquid Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Tissue Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Tissue Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Tissue Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Glioblastomas Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Glioblastomas Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Glioblastomas Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Head and Neck Cancers Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Head and Neck Cancers Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Head and Neck Cancers Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Non-Small Cell Lung Cancer (NSCLC) Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Non-Small Cell Lung Cancer (NSCLC) Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Non-Small Cell Lung Cancer (NSCLC) Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 37. Global Academic & Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Academic & Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Academic & Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Hospitals & Cancer Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hospitals & Cancer Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hospitals & Cancer Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global EGFR Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific EGFR Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 55. North America EGFR Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. North America EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 57. North America EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 58. North America EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 59. North America EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 60. Latin America EGFR Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Latin America EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 62. Latin America EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 63. Latin America EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Latin America EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 65. Europe EGFR Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Europe EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 67. Europe EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 68. Europe EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. Europe EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 70. Middle East EGFR Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Middle East EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 72. Middle East EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 73. Middle East EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. Middle East EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 75. Africa EGFR Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Africa EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 77. Africa EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 78. Africa EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. Africa EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 80. Global EGFR Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. ASEAN EGFR Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. ASEAN EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 83. ASEAN EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 84. ASEAN EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. ASEAN EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 86. GCC EGFR Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. GCC EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 88. GCC EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 89. GCC EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 90. GCC EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 91. European Union EGFR Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. European Union EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 93. European Union EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 94. European Union EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. European Union EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 96. BRICS EGFR Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. BRICS EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 98. BRICS EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 99. BRICS EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. BRICS EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 101. G7 EGFR Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. G7 EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 103. G7 EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 104. G7 EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. G7 EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 106. NATO EGFR Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. NATO EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 108. NATO EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 109. NATO EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. NATO EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 111. Global EGFR Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. United States EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 113. United States EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 114. United States EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 115. United States EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. United States EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 117. Canada EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 118. Canada EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 119. Canada EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 120. Canada EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Canada EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 122. Mexico EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 123. Mexico EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 124. Mexico EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 125. Mexico EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Mexico EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 127. Brazil EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 128. Brazil EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 129. Brazil EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 130. Brazil EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. Brazil EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 132. United Kingdom EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 133. United Kingdom EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 134. United Kingdom EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 135. United Kingdom EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. United Kingdom EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 137. Germany EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 138. Germany EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 139. Germany EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 140. Germany EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. Germany EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 142. France EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 143. France EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 144. France EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 145. France EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. France EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 147. Russia EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 148. Russia EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 149. Russia EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 150. Russia EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Russia EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 152. Italy EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 153. Italy EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 154. Italy EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 155. Italy EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Italy EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 157. Spain EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 158. Spain EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 159. Spain EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 160. Spain EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Spain EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 162. China EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 163. China EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 164. China EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 165. China EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. China EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 167. India EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 168. India EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 169. India EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 170. India EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. India EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 172. Japan EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 173. Japan EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 174. Japan EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 175. Japan EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Japan EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 177. Australia EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 178. Australia EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 179. Australia EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 180. Australia EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Australia EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 182. South Korea EGFR Tests Market Size, 2017-2032 (USD Million)
TABLE 183. South Korea EGFR Tests Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 184. South Korea EGFR Tests Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 185. South Korea EGFR Tests Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. South Korea EGFR Tests Market Size, by End-Users, 2017-2032 (USD Million)
TABLE 187. Global EGFR Tests Market Share, by Key Player, 2025
TABLE 188. Global EGFR Tests Market, Key Experts

Companies Mentioned

  • 3B BlackBio Dx Limited
  • Abbexa Ltd.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • AstraZeneca plc
  • Beijing ACCB Biotech Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biomatik Corporation
  • F. Hoffmann-La Roche AG
  • Foundation Medicine, Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Luminex Corporation
  • MyBiosource, Inc.
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • RainSure Scientific
  • Shanghai Korain Biotech Co., Ltd.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Albumin & Creatinine Tests Market - Global Forecast 2026-2032 - Product Image

Albumin & Creatinine Tests Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Kidney Function Tests Market - Global Forecast 2026-2032 - Product Image

Kidney Function Tests Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Creatinine Measurement - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Creatinine Measurement - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • Global
From
Companion Diagnostic Tests in Oncology - Global Strategic Business Report - Product Image

Companion Diagnostic Tests in Oncology - Global Strategic Business Report

  • Report
  • 501 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.